{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:51:07Z","timestamp":1751395867024,"version":"3.40.5"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Preventive chemotherapy (PC) is a central strategy for control and elimination of neglected tropical diseases (NTDs). Increased emphasis has been given to \u201cintegration\u201d of NTD programs within health systems and coadministration of NTD drugs offers significant programmatic benefits. Guidance from the World Health Organization (WHO) reflects current evidence for safe drug coadministration and highlights measures to prevent choking of young children during PC.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology<\/jats:title>\n<jats:p>To understand how coadministration of NTD drugs might affect PC safety, we reviewed literature on choking risk in young children and safety of coadministered NTD drugs. To understand current practices of drug coadministration, we surveyed 15 NTD program managers and implementing partners.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Principal findings<\/jats:title>\n<jats:p>In high-income countries, choking on medication is an infrequent cause of death in young children. In low-resource settings, data are limited, but age-appropriate drug formulations are less available. During PC, fatal choking, although infrequent, occurs primarily in young children; forcing them to swallow tablets appears to be the major risk factor. The WHO currently recommends 6 drugs and 5 possible drug combinations for use in PC. Of 105 nations endemic for the 5 PC-NTDs, 72 (68.6%) are co-endemic for 2 or more diseases and could benefit from drug coadministration during PC. All 15 survey respondents reported coadministering medications during PC. Reported responses to a child refusing to take medicine included: not forcing the child to do so (60.0%), encouraging the child (46.7%), bringing the child back later (26.7%), offering powder for oral suspension (POS) for azithromycin (13.3%), and having parents or community members intervene to calm the child (6.7%).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Coadministration of NTD drugs during PC appears to be increasingly common. Safety of coadministered PC drugs requires attention to choking prevention, use of approved drug combinations, and increased access to age-appropriate drug formulations.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0010700","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T18:53:03Z","timestamp":1664477583000},"page":"e0010700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety of integrated preventive chemotherapy for neglected tropical diseases"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-1216","authenticated-orcid":true,"given":"Allan M.","family":"Ciciriello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"LaCon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5949-7475","authenticated-orcid":true,"given":"David G.","family":"Addiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"pntd.0010700.ref001","first-page":"468","article-title":"Summary of global update on implementation of preventive chemotherapy against NTDs in 2020","volume":"38","author":"World Health Organization","year":"2021","journal-title":"Wkly Epidemiol Rec"},{"key":"pntd.0010700.ref002","unstructured":"Moloo A. Neglected tropical diseases: 2020 preventive chemotherapy treatment coverage declines due to COVID-19 disruptions. 2021 [cited 2021 Oct 14]. In: World Health Organization [Internet]. Available from: https:\/\/www.who.int\/news\/item\/24-09-2021-neglected-tropical-diseases-2020-preventive-chemotherapy-treatment-coverage-declines-due-to-covid-19-disruptions."},{"key":"pntd.0010700.ref003","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12936-017-1830-z","article-title":"Upon entering an age of global ivermectin-based mass drug administration for neglected tropical diseases and malaria","volume":"16","author":"FO Richards","year":"2017","journal-title":"Malar J"},{"volume-title":"Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030","year":"2020","author":"World Health Organization","key":"pntd.0010700.ref004"},{"volume-title":"Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation: executive summary","year":"2012","author":"World Health Organization","key":"pntd.0010700.ref005"},{"issue":"1","key":"pntd.0010700.ref006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14787210.7.1.37","article-title":"Prospects for the control of neglected tropical diseases by mass drug administration","volume":"7","author":"HL Smits","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1645","key":"pntd.0010700.ref007","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0434","article-title":"The contribution of mass drug administration to global health: past, present, and future","volume":"369","author":"JP Webster","year":"2014","journal-title":"Philos Trans R Soc B"},{"issue":"6","key":"pntd.0010700.ref008","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.16","article-title":"Mass drug administration and integrated control for the world\u2019s high prevalence neglected tropical diseases","volume":"85","author":"PJ Hotez","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"pntd.0010700.ref009","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2471\/BLT.06.029652","article-title":"Integration of mass drug administration programs in Nigeria: The challenge of schistosomiasis","volume":"84","author":"FO Richards","year":"2006","journal-title":"Bull World Health Organ"},{"key":"pntd.0010700.ref010","article-title":"Impact of community-based integrated mass drug administration on schistosomiasis and soil-transmitted helminth prevalence in Togo","author":"RN Bronzan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0010700.ref011","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4269\/ajtmh.2011.10-0635","article-title":"Costs of integrated mass drug administration for neglected tropical diseases in Haiti","volume":"85","author":"AS Goldman","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010700.ref012","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S2214-109X(15)00047-9","article-title":"Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modeling study","volume":"3","author":"NC Lo","year":"2015","journal-title":"Lancet Glob Health"},{"key":"pntd.0010700.ref013","unstructured":"World Health Organization. Action Against Worms. PPC Newsletter. 2007;8."},{"volume-title":"Assuring safety of preventive chemotherapy interventions for the control of neglected tropical diseases","year":"2011","author":"World Health Organization","key":"pntd.0010700.ref014"},{"key":"pntd.0010700.ref015","article-title":"Risk of adverse swallowing events and choking during deworming for preschool-aged children","author":"JW Kernell","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"volume-title":"Safety in administering medicines for neglected tropic diseases","year":"2021","author":"World Health Organization","key":"pntd.0010700.ref016"},{"volume-title":"How to add deworming to vitamin A distribution","year":"2004","author":"World Health Organization","key":"pntd.0010700.ref017"},{"volume-title":"Promoting safety of medicines for children","year":"2007","author":"World Health Organization","key":"pntd.0010700.ref018"},{"key":"pntd.0010700.ref019","unstructured":"World Health Organization. Lymphatic filariasis\u2013Status of Mass Drug Administration: 2020. 2020 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/apps.who.int\/neglected_diseases\/ntddata\/lf\/lf.html."},{"key":"pntd.0010700.ref020","unstructured":"World Health Organization. Onchocerciasis\u2013Status of endemicity of onchocerciasis: 2019. 2020 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/apps.who.int\/neglected_diseases\/ntddata\/oncho\/onchocerciasis.html."},{"key":"pntd.0010700.ref021","unstructured":"World Health Organization. Schistosomiasis\u2013Status of endemic countries: 2020. 2020 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/apps.who.int\/neglected_diseases\/ntddata\/sch\/sch.html."},{"key":"pntd.0010700.ref022","unstructured":"World Health Organization. Soil-transmitted helminthiases\u2013Number of children (Pre-SAC and SAC) requiring preventative chemotherapy for soil-transmitted helminthiases: 2019. 2020 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/apps.who.int\/neglected_diseases\/ntddata\/sth\/sth.html."},{"key":"pntd.0010700.ref023","unstructured":"World Health Organization. Trachoma\u2013Status of elimination of trachoma as a public health problem: 2020. 2020 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/apps.who.int\/neglected_diseases\/ntddata\/trachoma\/trachoma.html."},{"key":"pntd.0010700.ref024","unstructured":"World Health Organization. Diseases\u2013Schistosomiasis. 2019 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/espen.afro.who.int\/diseases\/schistosomiasis."},{"key":"pntd.0010700.ref025","unstructured":"World Health Organization. Diseases\u2013Soil-transmitted helminthiasis. 2019 [cited 2021 Apr 19]. In: World Health Organization [Internet]. Available from: https:\/\/espen.afro.who.int\/diseases\/soil-transmitted-helminthiasis."},{"key":"pntd.0010700.ref026","volume-title":"Helminth control in school-age children: a guide for managers of control programmes","author":"World Health Organization","year":"2011","edition":"2"},{"key":"pntd.0010700.ref027","unstructured":"World Health Organization. Control of Neglected Tropical Diseases. 2022. [cited 2022 Sep 8]. In: World Health Organization [Internet]. Available from: https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/lymphatic-filariasis\/global-programme-to-eliminate-lymphatic-filariasis."},{"key":"pntd.0010700.ref028","unstructured":"World Health Organization. Lymphatic filariasis. 2022 [cited 2022 Sep 8]. In: World Health Organization [Internet]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lymphatic-filariasis."},{"key":"pntd.0010700.ref029","unstructured":"World Health Organization. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. Geneva: World Health Organization; 2017."},{"issue":"50","key":"pntd.0010700.ref030","first-page":"629","article-title":"Schistosomiasis and soil-transmitted helminthiases: numbers of people treated in 2019","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"issue":"43","key":"pntd.0010700.ref031","first-page":"509","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2019","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"pntd.0010700.ref032","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/lary.24547","article-title":"Development of a preliminary pediatric tracheal growth model from magnetic resonance images","volume":"124","author":"RL Amendola","year":"2014","journal-title":"Laryngoscope"},{"issue":"31","key":"pntd.0010700.ref033","first-page":"353","article-title":"WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2020","volume":"96","author":"World Health Organization","year":"2021","journal-title":"Wkly Epidemiol Rec"},{"key":"pntd.0010700.ref034","unstructured":"PopulationPyramid.net. Population Pyramids of the World from 1950 to 2100: Ethiopia 2020. 2019 [cited 2022 Feb 2]. In: Creative Commons [Internet]. Available from: https:\/\/www.populationpyramid.net\/ethiopia\/2020\/."},{"issue":"2","key":"pntd.0010700.ref035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1179\/136485908X252322","article-title":"Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria","volume":"102","author":"A Eigege","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"pntd.0010700.ref036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000171","article-title":"Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study","volume":"2","author":"KA Mohammed","year":"2008","journal-title":"PLOS Negl Trop Dis"},{"key":"pntd.0010700.ref037","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.trstmh.2005.05.017","article-title":"Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations","volume":"100","author":"K Na-Bangchang","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0010700.ref038","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.trstmh.2010.11.012","article-title":"A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda","volume":"105","author":"H Namwanje","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pntd.0010700.ref039","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/cid\/ciy574","article-title":"Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo","volume":"68","author":"M Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"pntd.0010700.ref040","first-page":"6","article-title":"Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm interventional trial","author":"L Romani","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pntd.0010700.ref041","article-title":"Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases","author":"LN John","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"29","key":"pntd.0010700.ref042","article-title":"Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial","volume":"19","author":"LN John","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"76","key":"pntd.0010700.ref043","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4269\/ajtmh.2007.76.1153","article-title":"Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in health volunteers","volume":"76","author":"GW Amsden","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0010700.ref044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002221","article-title":"A Cluster Randomized Study of The Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults in Sikasso, Mali","volume":"7","author":"YI Coulibaly","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010700.ref045","first-page":"2","article-title":"The Effect of Azithromycin on Ivermectin Pharmacokinetics\u2013A Population Pharmacokinetic Model Analysis","author":"A El-Tahwaty","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0010700.ref046","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1360-2276.2003.01124.x","article-title":"Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages","volume":"8","author":"R Ndyomugyenyi","year":"2003","journal-title":"Trop Med Int Health"},{"key":"pntd.0010700.ref047","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1473-3099(14)71050-3","article-title":"Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial","volume":"15","author":"B Speich","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"pntd.0010700.ref048","unstructured":"National Safety Council. Deaths by Age and Cause. 2021 [cited 2021 Dec 1]. In: National Safety Council [Internet]. Available from: https:\/\/injuryfacts.nsc.org\/all-injuries\/deaths-by-demographics\/deaths-by-age\/data-details\/."},{"issue":"11","key":"pntd.0010700.ref049","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.socscimed.2009.08.024","article-title":"Pediatric therapeutics and medicine administration in resource-poor settings: a review of barriers and an agenda for interdisciplinary approaches to improving outcomes","volume":"69","author":"SR Craig","year":"2009","journal-title":"Soc Sci Med"},{"issue":"8","key":"pntd.0010700.ref050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/adc.2009.180000","article-title":"Realities of paediatric pharmacotherapy in the developing world","volume":"96","author":"K Hoppu","year":"2011","journal-title":"Arch Dis Child"},{"issue":"3","key":"pntd.0010700.ref051","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/17425247.2012.655268","article-title":"Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases","volume":"9","author":"A Sosnik","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"pntd.0010700.ref052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058303","article-title":"Children\u2019s medicines in Tanzania: a national survey of administration practices and preferences","volume":"8","author":"LV Adams","year":"2018","journal-title":"PLoS ONE"},{"key":"pntd.0010700.ref053","unstructured":"Global Health Innovative Technology Fund. GHIT and EDCTP co-invest additional 7.8 million Euro in the Pediatric Praziquantel Consortium\u2019s access program to ensure treatment of schistosomiasis for preschool-aged children. 2021 [cited 2021 Apr 19]. In: Global Health Innovative Technology Fund [Internet]. Available from: https:\/\/www.ghitfund.org\/newsroom\/press\/detail\/302\/."},{"key":"pntd.0010700.ref054","unstructured":"Pediatric Praziquantel Consortium. The pediatric formulation. 2021 [cited 2021 Apr 19]. In: Pediatric Praziquantel Consortium [Internet]. Available from: https:\/\/www.pediatricpraziquantelconsortium.org\/node\/36."},{"issue":"1","key":"pntd.0010700.ref055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/cts.12601","article-title":"Bioavailability of Orally Dispersible Tablet Formulations of Levo- and Racemic Praziquantel: Two Phase I Studies","volume":"12","author":"WM Bagchus","year":"2019","journal-title":"Clin Transl Sci"},{"key":"pntd.0010700.ref056","first-page":"2012","article-title":"Safety of a New Chewable Formulation of Mebendazole for Preventative Chemotherapy Interventions to Treat Young Children in Countries with Moderate-to-High Prevalence of Soil Transmitted Helminth Infections","author":"AJ Friedman","year":"2012","journal-title":"J Trop Med"},{"issue":"7","key":"pntd.0010700.ref057","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.trstmh.2012.03.013","article-title":"Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety","volume":"106","author":"AM Navaratnam","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0010700.ref058","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100556","article-title":"Efficacy, safety and acceptability of a new chewable formulation versus the solid tablet of mebendazole against hookworm infection in children: An open-label, randomized controlled trial","volume":"27","author":"MS Palmeirim","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"6","key":"pntd.0010700.ref059","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4269\/ajtmh.17-0108","article-title":"Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study","volume":"97","author":"SA Silber","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0010700.ref060","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijpharm.2015.09.019","article-title":"Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children","volume":"495","author":"R Trastullo","year":"2015","journal-title":"Int J Pharm"},{"issue":"1","key":"pntd.0010700.ref061","article-title":"The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK\/PD-driven randomised controlled trial of praziquantel in children under 4 years of age","volume":"22","author":"EL Webb","year":"2021","journal-title":"Trials"},{"key":"pntd.0010700.ref062","unstructured":"International Trachoma Initiative. Zithromax Management Guide 2019. International Trachoma Initiative; 2019."},{"issue":"5","key":"pntd.0010700.ref063","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000","volume":"68","author":"SI McLaughlin","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"pntd.0010700.ref064","article-title":"The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study","volume":"16","author":"GJ Weil","year":"2019","journal-title":"PLoS Med"},{"key":"pntd.0010700.ref065","article-title":"An observational assessment of the safety of mass drug administration for trachoma in Ethiopian children","author":"AM Ciciriello","year":"2022","journal-title":"Trans R Soc Trop Med Hyg"},{"volume-title":"To err is human: Building a safer health system","year":"1999","author":"LT Kohn","key":"pntd.0010700.ref066"},{"issue":"106","key":"pntd.0010700.ref067","first-page":"37","article-title":"Safe Mass Drug Administration and Trachoma Elimination","volume":"32","author":"D Addiss","year":"2019","journal-title":"Community Eye Health"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T18:54:22Z","timestamp":1664477662000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010700"}},"subtitle":[],"editor":[{"given":"Ran","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010700","relation":{},"ISSN":["1935-2735"],"issn-type":[{"type":"electronic","value":"1935-2735"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}